In PNAS this week: gut microbiome-diet relationships in large, East African herbivore species, breast cancer features that boost susceptibility to neoadjuvant chemotherapy, and more.
The dispute regarding the Wellcome Sanger Institute's use of DNA samples from African individuals could weaken trust between researchers and African populations, Science writes.
The Scientist writes that the announcement of Islamic State's Abu Bakr al-Baghdadi's death suggested that his identity might have been confirmed with rapid DNA testing.
Reuters reports that Scott Gottlieb, the former Food and Drug Administration commissioner, plans to focus in part on new antibiotics in his venture capital role.
In an op-ed at the Washington Post, the University of Pennsylvania's Ravi Parikh writes that research conducted by for-profit companies shouldn't be overlooked.
